Startup TELABio Raises $45.3 Million
It’s pretty rare to see well-funded medical device companies fly so smoothly under the radar, but Pennsylvania surgical reconstruction startup TELA Bio has done just that – it’s raised $45.3 million in equity, according to a regulatory filing. But that’s practically all we know.
The company held two funding rounds prior – $6 million in 2013 and $16.1 million in 2012. It’s led by Antony Koblish, who led orthobiologics maker Orthovita until it was sold three years ago to Stryker for $316 million.
Orthovita – and now Stryker – creates regenerative protein-based products for synthetic bone grafts. So what does TELA Bio do? Probably something quite similar.
Help employers find you! Check out all the jobs and post your resume.
The company held two funding rounds prior – $6 million in 2013 and $16.1 million in 2012. It’s led by Antony Koblish, who led orthobiologics maker Orthovita until it was sold three years ago to Stryker for $316 million.
Orthovita – and now Stryker – creates regenerative protein-based products for synthetic bone grafts. So what does TELA Bio do? Probably something quite similar.
Help employers find you! Check out all the jobs and post your resume.